besity has been considered to be associated with cardiovascular diseases: as body mass index (BMI) increases, the risk of congestive heart failure (CHF) increases. 1 In the Guidelines for Treatment of Chronic Heart Failure (JCS 2010) in Japan, physicians are recommended to ask obese patients with CHF to reduce their caloric intake in order to lose weight.
Recent reports, however, have shown that obese patients with CHF have more favorable clinical outcomes. 2 These favorable effects of obesity, termed the "obesity paradox", are also seen in patients with other cardiovascular diseases, such as hypertension and coronary heart disease. 3 This phenomenon might be partly due to selection bias. In a large meta-analysis (total n=28,209), however, obesity was still related to better outcomes after adjusting for known risk factors. 4 Although Japanese patients tend to be less obese than European/US patients, and the average BMI is much lower in Japan, only a few studies are available on Japanese populations. 5, 6 The purpose of the present study was therefore to investigate the impact of BMI on prognosis after the development of CHF.
Methods
The study protocol was approved by the ethics committee of The Jikei University School of Medicine (23-003(6464) ). Patients with CHF who had been admitted to The Jikei University Hospital from April 2007 through March 2011 and then were followed up after discharge at the outpatient clinic were reviewed. CHF was diagnosed by 2 or more cardiologists on the basis of the Framingham criteria. 7 Patients were excluded if they had CHF complicated by acute myocardial infarction, were receiving or were beginning to receive dialysis during the follow-up period, or had undergone cardiac surgery during
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the follow-up period. 7 Based on these selection criteria, 219 patients were enrolled. The average duration of follow-up was 452 days. The BMI was calculated as body weight (kg) divided by the square of the height (m). The estimated glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Disease equation 8 coefficient modified for Japanese patients: 9 eGFR =194 × Cr -1.094 × age -0.287 (ml · min -1 · 1.73 m -2 ). For female subjects, eGFR was multiplied by a correction factor of 0.739.
The patients were divided into 4 groups according to BMI quartiles. In some analyses, BMI was used as a continuous variable. The primary endpoint in the present study was defined as all-cause death or unplanned CHF hospitalization. We also examined the following secondary endpoints: (1) all-cause death; (2) cardiac death; (3) unplanned CHF hospitalization; and (4) cardiac death or unplanned CHF hospitalization. Background characteristics, characteristics of CHF, and prescriptions at discharge were also compared between the 4 groups. Hypertension, diabetes mellitus (DM), and dyslipidemia were defined as described previously. 7,10 All measurements, including echocardiography, were done on the day of admission. CHF with preserved ejection fraction (EF) was defined as EF >50%, as estimated on echocardiography.
Continuous variables are expressed as mean ± SE and were compared using analysis of variance (ANOVA). Categorical variables are expressed as percentages and were compared using the chi-square test. Cumulative event-free curves were constructed with the Kaplan -Meier method and compared on log-rank test. Univariate analysis or multivariate analysis for predictors of primary and secondary endpoints was performed using the Cox proportional hazard test. Statistical significance was set at P<0.05.
Results
The BMI of patients included in the present study is given in Figure 1 . These patients were divided into 4 groups according to BMI quartiles. Figure 2 shows the event-free Kaplan -Meier curve according to BMI quartiles. High BMI was associated with better outcomes. The all-cause death or CHF hospitalization, all-cause death, CHF hospitalization, and cardiac death or CHF hospitalization, but not cardiac death, itself were associated with the BMI quartiles. Baseline patient characteristics are listed in Table 1 . Patients with higher BMI were younger, more likely to be male, and have hypertension and DM. Table 2 lists physical and laboratory examination data obtained on admission. The prevalence of atrial fibrillation (AF) was lower in the high-BMI group. The serum hemoglobin (Hb) and sodium (Na) levels were higher and blood urea nitrogen (BUN) levels were lower in the high-BMI group. Figure 3 shows plasma B-type natriuretic peptide (BNP) levels for each BMI quartile. Plasma BNP levels were lower in the high-BMI patients. There were no differences between the BMI quartiles in prescriptions at discharge ( Table 3) .
The variables identified in Tables 1-3 and levels of plasma BNP were used in univariate analysis for predictors of allcause death or CHF hospitalization. The predictors identified on univariate analysis were age, prior CHF hospitalization, eGFR, serum Hb and Na, BUN and plasma BNP ( Table 4) .
Characteristics that differed significantly in BMI quartiles and factors that were identified as predictors of all-cause death or CHF hospitalization based on a univariate analysis were included in multivariate analysis. After adjusting for age, gender, hypertension, DM, prior CHF hospitalization, serum Hb and Na levels, eGFR, BUN levels, AF on admission, and the plasma BNP levels, the BMI was found to be associated with all-cause death or CHF hospitalization, CHF hospitalization, and cardiac death or CHF hospitalization. The BMI was not associated with either all-cause death or cardiac death, probably due to the small number of deaths ( Table 5) .
Discussion
The present study clearly demonstrates that higher BMI is associated with better clinical outcomes in Japanese patients hospitalized with CHF.
Distribution of BMI
Although the lifestyle of Japan has recently become more Figure 2 . Event-free Kaplan - Meier curves of (A) all-cause death or unplanned congestive heart failure (CHF) hospitalization; (B) all-cause death; (C) cardiac death; (D) unplanned CHF hospitalization; and (E) cardiac death or unplanned CHF hospitalization. Green line, Q1; pink line, Q2; yellow line, Q3; gray line, Q4.
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KOMUKAI K et al. westernized, 11 the physiques of Japanese people still tend to be different from European/US people. The distribution of BMI in the present study was comparable with Japanese studies, 5,6,12 but it was much lower than that reported in European/US studies. 13-15 Therefore, the cut-offs for classifying an individual as lean, normal, overweight, or obese should be different. In the present study, we used quartiles instead of lean/normal/overweight/obesity.
BNP in Obese Patients With CHF
Obese patients might be misdiagnosed as having CHF, or CHF in obese patients might not be severe. Although it is difficult to compare the severity of CHF, the New York Heart Association (NYHA) class and EF were not different between BMI quartiles. Plasma BNP is considered to be a good marker for the severity of CHF, but plasma BNP levels are affected by some extra-cardiac factors. The plasma BNP levels were found to be lower in overweight/obese CHF patients, even with similar hemodynamic severities of CHF. 16 The expression of natriuretic peptide clearance receptor (NPR-C) is known to increase in adipose tissues, but the level of N-terminal proBNP, which is not cleared by NPR-C, is also lower in higher BMI patients. 17, 18 In animal models, obesity is associated with a reduced production of natriuretic peptides. 19 Lower plasma BNP might therefore be associated with a favorable outcome in obese patients. In contrast, it is also possible that weak compensatory mechanisms (to increase BNP) may be harmful in some conditions in obese CHF patients. We included plasma BNP in multivariate analysis, and a higher BMI was still found to be associated with favorable outcomes. If CHF in high-BMI patients was underestimated due to a BMI-dependent modulation of clearance and/or the production of BNP, then the impact of BMI on clinical outcomes would be underestimated. Therefore, when plasma BNP was not included in multivariate analysis, a higher BMI was found to be more significantly associated with favorable outcomes than when plasma BNP was included.
Confounding Factors
High-BMI patients were younger and age was one of the predictors for an event on univariate analysis. Age was included in multivariate analysis, and higher BMI was associated with better outcomes on multivariate analysis. We also performed analyses after excluding younger patients aged ≤70 years; a higher BMI was associated with a lower number of events.
In the present study, serum Hb and Na levels increased and BUN decreased as BMI increased; all of them were associated with better outcomes. After adjusting for these variables, however, a higher BMI was found to be associated with a lower number of such events. Serum albumin level is considered to be associated with prognosis in patients with heart failure. 14 In the present study, the serum albumin levels were not different between the BMI quartiles and were not found to be a predictor for such events based on univariate analysis. Even when serum albumin levels were included in multivariate analysis, the results were the same (data not shown).
Mechanism for Obesity Paradox
The mechanisms of the obesity paradox in patients with CHF have been discussed elsewhere. 3 CHF is a catabolic state, and obese patients have more metabolic reserve. After adjusting for the serum albumin and Hb levels, a higher BMI was still associated with a better outcome. Variables other than serum albumin or Hb, however, might correctly reflect the nutrition status. Adipose tissues might have a protective effect in CHF. Tumor necrosis factor (TNF)-α level is known to increase in CHF and thus result in a worsening of CHF. Adipose tissue neutralizes TNF-α by producing soluble TNF-α receptor. 20 As mentioned here, plasma BNP has been established as a marker for CHF. Therefore, lower BNP in higher BMI patients might contribute to a better prognosis. Non-significant variables: gender, hypertension, DM, dyslipidemia, ischemic heart disease, NYHA class, SBP, heart rate, EF, preserved EF, serum K, serum albumin, AF on admission, ACEI/ARBs, β-blockers, Ca antagonists, loop diuretics, aldosterone blockers, statins. HR, hazard ratio; CI, confidence interval; BNP, B-type natriuretic peptide. Other abbreviations see in Tables 1-3 .
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Study Limitations
Several limitations of this study should be considered. First, this is a retrospective study and not a prospective study. In contrast, prospective studies have a strong selection bias for patient inclusion. This study included consecutive patients admitted to hospital with CHF, and the exclusion criteria were the same as those in our previous study. 7 Therefore, the selection bias for patient inclusion was minimized. Second, the results might be confounded by some unknown and/or unmeasured variables. In contrast to previous studies, the severity of CHF was estimated using EF, NYHA class, and plasma BNP on admission. The nutrition status was also estimated based on serum Hb and serum albumin levels, but there might still be some unknown/ unmeasured variables left to consider. Third, the sample size in the present study was relatively small. Even so, the results were nevertheless found to be clear and statistically significant. Fourth, the only variable used to estimate adipose tissue in this study was BMI. Fifth, we could not observe any U-shape phenomenon between BMI and clinical outcomes. The distribution of BMI in the present study was lower than that reported in a previous European/US study. 13- 15 The clinical outcomes of Japanese CHF patients with much higher BMI levels should therefore be investigated in future. Finally, the present study failed to show any statistically significant association between systolic blood pressure (BP) and outcomes. Systolic BP has previously been shown to be a powerful predictor for clinical outcomes in patients with CHF, but those studies mainly included patients with reduced EF. 21 Recent studies have shown that the relationship between systolic BP and outcomes is complex and varies with systolic function. 22, 23 The present study included a relatively large number of CHF patients with preserved EF. Further studies focused on systolic BP are needed in order to determine its value as a predictor in patients with CHF. On multivariate analysis, the co-variables were age, gender, hypertension, DM, prior CHF hospitalization, serum Hb and Na levels, eGFR, BUN, AF on admission, and plasma BNP. Abbreviations see in Tables 1,2 ,4. BMI and CHF
Conclusion
A higher BMI is associated with better clinical outcomes in Japanese patients hospitalized with CHF.
